(UTV | COLOMBO) – The Expert Committee of the National Medicines Regulatory Authority (NMRA) has approved the emergency use of the Sinopharm COVID-19 vaccine in Sri Lanka.
The WHO had yesterday approved China’s Sinopharm Covid-19 vaccine for emergency use, easing the way for poorer nations to get access to another much-needed shot to help end the pandemic.
The NMRA has already approved the use of the Oxford AstraZeneca Covishield vaccine, Sputnik V vaccine and Pfizer COVID-19 vaccine in Sri Lanka.
